We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype.
- Authors
Zhu, Mengting; Rovella, Valentina; Scimeca, Manuel; Mauriello, Alessandro; Shi, Yufang; Bischof, Julia; Woodsmith, Jonathan; Anselmo, Alessandro; Melino, Gerry; Tisone, Giuseppe; Agostini, Massimiliano
- Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, occurring predominantly in patients with underlying chronic liver disease and cirrhosis. Here, we describe a case of a 62-year-old man that was admitted to our hospital and diagnosed with HCC where the cancer has already metastasized to the retroperitoneum and peritoneum. In order to better characterize the HCC, both the cancerous liver tissue and the adjacent normal liver tissue of the patient were collected and subjected to a genomic, transcriptomic and proteomic analysis. Our patient carries a highly mutated HCC, which is characterized by both somatic mutation in the following genes ALK, CDK6, TP53, PGR. In addition, we observe several molecular alterations that are associated with potential therapy resistance, for example the expression of the organic-anion-transporting polypeptide (OATP) family members B1 and B3, that mediate the transport of the anticancer drugs, has been found decreased. Overall, our molecular profiling potentially classify the patient with poor prognosis and possibly displaying resistance to pharmacological therapy.
- Subjects
TRANSCRIPTOMES; CIRRHOSIS of the liver; LIVER diseases; RETROPERITONEUM
- Publication
Discover Oncology, 2024, Vol 15, Issue 1, p1
- ISSN
2730-6011
- Publication type
Article
- DOI
10.1007/s12672-023-00850-9